Starling Oncology, Inc.
STLN- Exchange
- Nasdaq
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- SEC CIK
- 0001799191
In the last 90 days, Starling Oncology, Inc. insiders filed 3 open-market purchases and 2 sales; 119 institutions reported holding it in 13F filings for Q2 2026, worth $217.6M in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding Starling Oncology, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 39 | 2 | 34 | −3 |
| Shares | 18.7M | 1.95M | 20.6M | +3.84M (+22.9%) |
| Value | $8.60M | $899.2K | $6.73M | −$972.7K (−12.6%) |
2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (3)
Institutions that held Starling Oncology, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Kent Lake PR LLC | 2,000,000 | $653.8K | 0.26% |
| BlackRock, Inc. | 252,940 | $82.7K | 0.00% |
| Two Sigma Securities, LLC | 16,997 | $5.56K | 0.00% |
Sold out (6)
Institutions that held Starling Oncology, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Hongkou Capital LP | 802,965 | $369.4K |
| Millennium Management LLC | 109,207 | $50.2K |
| JustInvest LLC | 17,984 | $8.27K |
| Mariner, LLC | 10,884 | $5.01K |
| Rhumbline Advisers | 2,175 | $1.00K |
| Royal Bank of Canada | 130 | $0 |
Not filed for Q3 2024 yet (2)
Institutions that held Starling Oncology, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Kent Lake Capital LLC | 1,750,000 | $805.0K |
| BlackRock Inc. | 204,814 | $94.2K |